Obducat (OBDU) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
24 Jul, 2026Executive summary
Achieved a marginally positive operating result in Q2 2026, with revenues up 84% year-over-year and a gross margin of 57%.
Secured a major three-year Foundry Services contract worth at least 115 MSEK with a European photonics customer, primarily serving the defense sector.
Completed a directed share issue raising 40 MSEK, strengthening liquidity and supporting delivery on a robust order backlog.
Order intake for the first half of 2026 reached 137 MSEK, surpassing the communicated 12-month rolling target of 100 MSEK, supporting the growth agenda.
Financial highlights
Q2 2026 revenues: 28.3 MSEK (up from 15.4 MSEK in Q2 2025); H1 2026 revenues: 41.3 MSEK (up from 22.1 MSEK).
Gross margin in Q2: 57% (53% in Q2 2025); H1 gross margin: 61% (55% in H1 2025).
Q2 operating result: 0.1 MSEK (improved from -4.4 MSEK); H1 operating result: -6.5 MSEK (improved from -13.8 MSEK).
Q2 result before tax: 2.2 MSEK (from -6.9 MSEK); H1 result before tax: -8.3 MSEK (from -20.3 MSEK).
Q2 cash flow: 24.8 MSEK (from -1.2 MSEK); H1 cash flow: 30.0 MSEK (from -1.4 MSEK).
Outlook and guidance
Targeting annual revenue and order intake above 100 MSEK on a rolling 12-month basis.
Aiming for a minimum annual revenue growth rate (CAGR) of 15% between 2026 and 2028.
Focus remains on converting strong order intake into deliveries, revenues, and improved cash flow.
Latest events from Obducat
- Revenue up 94% year-over-year, with strong order backlog and improved financial stability.OBDU
Q1 20268 May 2026 - Sharp revenue drop and operating loss in 2025; liquidity stabilized by rights issue in 2026.OBDU
Q4 202520 Feb 2026 - Sharp revenue drop and losses prompt new financing and strategic focus on 2026 recovery.OBDU
Q3 202514 Nov 2025 - Revenue and order intake fell significantly, with liquidity and financing risks remaining acute.OBDU
Q2 202525 Jul 2025 - Revenue up in Q3, but weak order intake and financing risks threaten ongoing operations.OBDU
Q3 202413 Jun 2025 - Revenue and margins improved in Q2, with higher order intake and a positive H2 outlook.OBDU
Q2 202413 Jun 2025 - Order intake rose and liquidity improved after a 35 MSEK rights issue, despite a wider Q1 loss.OBDU
Q1 20256 Jun 2025 - Order intake rebounded in Q4, but full-year results were impacted by delays and financing needs.OBDU
Q4 20245 Jun 2025